Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 5 |
| 1.1 List of Tables | 4 | 2 |
| 1.2 List of Figures | 6 | 1 |
| 2 Introduction | 7 | 1 |
| 2.1 Vagus Nerve Stimulators Overview | 7 | 1 |
| 3 Products under Development | 8 | 5 |
| 3.1 Vagus Nerve Stimulators - Pipeline Products by Stage of Development | 8 | 1 |
| 3.2 Vagus Nerve Stimulators - Pipeline Products by Territory | 9 | 1 |
| 3.3 Vagus Nerve Stimulators - Pipeline Products by Regulatory Path | 10 | 1 |
| 3.4 Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date | 11 | 1 |
| 3.5 Vagus Nerve Stimulators - Ongoing Clinical Trials | 12 | 1 |
| 4 Vagus Nerve Stimulators - Pipeline Products under Development by Companies | 13 | 2 |
| 4.1 Vagus Nerve Stimulators Companies - Pipeline Products by Stage of Development | 13 | 1 |
| 4.2 Vagus Nerve Stimulators - Pipeline Products by Stage of Development | 14 | 1 |
| 5 Vagus Nerve Stimulators Companies and Product Overview | 15 | 42 |
| 5.1 BioControl Medical Company Overview | 15 | 1 |
| 5.1.1 BioControl Medical Pipeline Products &Ongoing Clinical Trials Overview | 15 | 2 |
| 5.2 Boston Scientific Corporation Company Overview | 17 | 1 |
| 5.2.1 Boston Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 17 | 4 |
| 5.3 CerboMed GmbH Company Overview | 21 | 1 |
| 5.3.1 CerboMed GmbH Pipeline Products &Ongoing Clinical Trials Overview | 21 | 1 |
| 5.4 Cerebral RX Ltd. Company Overview | 22 | 1 |
| 5.4.1 Cerebral RX Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 22 | 1 |
| 5.5 Cyberonics, Inc. Company Overview | 23 | 1 |
| 5.5.1 Cyberonics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 4 |
| 5.6 DuoCure Ltd. Company Overview | 27 | 1 |
| 5.6.1 DuoCure Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
| 5.7 ElectroCore, LLC Company Overview | 28 | 1 |
| 5.7.1 ElectroCore, LLC Pipeline Products &Ongoing Clinical Trials Overview | 28 | 6 |
| 5.8 LivaNova PLC Company Overview | 34 | 1 |
| 5.8.1 LivaNova PLC Pipeline Products &Ongoing Clinical Trials Overview | 34 | 6 |
| 5.9 Medical University of South Carolina Company Overview | 40 | 1 |
| 5.9.1 Medical University of South Carolina Pipeline Products &Ongoing Clinical Trials Overview | 40 | 2 |
| 5.10 MicroTransponder Inc. Company Overview | 42 | 1 |
| 5.10.1 MicroTransponder Inc. Pipeline Products &Ongoing Clinical Trials Overview | 42 | 7 |
| 5.11 Neurostream Technologies G.P. (Inactive) Company Overview | 49 | 1 |
| 5.11.1 Neurostream Technologies G.P. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 49 | 2 |
| 5.12 Purdue University Company Overview | 51 | 1 |
| 5.12.1 Purdue University Pipeline Products &Ongoing Clinical Trials Overview | 51 | 1 |
| 5.13 Setpoint Medical Corp Company Overview | 52 | 1 |
| 5.13.1 Setpoint Medical Corp Pipeline Products &Ongoing Clinical Trials Overview | 52 | 4 |
| 5.14 Trifectas Medical Corp. Company Overview | 56 | 1 |
| 5.14.1 Trifectas Medical Corp. Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 6 Vagus Nerve Stimulators- Recent Developments | 57 | 36 |
| 6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 | 57 | 1 |
| 6.2 Oct 19, 2016: SetPoint Medical Presents Positive Clinical Results in Crohn s Disease | 58 | 1 |
| 6.3 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results | 59 | 1 |
| 6.4 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer | 60 | 1 |
| 6.5 Sep 29, 2016: LivaNova Announces Half-Year Financial Report | 61 | 8 |
| 6.6 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results | 69 | 1 |
| 6.7 Aug 01, 2016: LivaNova Names Chief Operating Officer | 70 | 1 |
| 6.8 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 71 | 1 |
| 6.9 Jul 26, 2016: Use of electroCore s therapy reduces frequency of migraine attacks in chronic patients | 72 | 1 |
| 6.10 Jul 21, 2016: Reorganization of electroCore management team as Frank Amato becomes CEO and founder JP Errico becomes Chief Science and Strategy Officer | 73 | 1 |
| 6.11 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results | 73 | 2 |
| 6.12 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 75 | 1 |
| 6.13 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization | 75 | 1 |
| 6.14 Jul 05, 2016: Breakthrough First-in-Human Study Shows Vagus Nerve Stimulation Significantly Reduces Rheumatoid Arthritis Symptoms, Inhibits Cytokine Production | 76 | 1 |
| 6.15 Jun 29, 2016: ElectroCore Raises USD1.5 Million in Venture Financing | 77 | 1 |
| 6.16 Jun 24, 2016: Five presentations at AHS meeting provide new insights into non-invasive vagus nerve stimulation s mode of action | 77 | 1 |
| 6.17 Jun 15, 2016: ElectroCore s non-invasive vagus nerve stimulation (nVNS) demonstrates efficacy in preventing cluster headache and menstrual migraine | 78 | 1 |
| 6.18 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 78 | 1 |
| 6.19 Jun 06, 2016: Seven presentations on electroCore s treatment for cluster headache and migraine will feature at American Headache Society science meeting | 79 | 1 |
| 6.20 May 31, 2016: Ergoresearch announce the nomination of an Executive Vice-President | 80 | 1 |
| 6.21 May 27, 2016: Ergoresearch Reports its Results for the Quarter Ended March 31, 2016 | 81 | 1 |
| 6.22 May 17, 2016: GammaCore is both effective and cost effective for the treatment of cluster headache | 81 | 1 |
| 6.23 May 04, 2016: LivaNova Reports First Quarter 2016 Results | 82 | 1 |
| 6.24 Apr 19, 2016: Studies presented at the American Academy of Neurology meeting confirm nVNS is stimulating the vagus nerve non-invasively and that nVNS can be effective in preventing menstrual migraine | 83 | 1 |
| 6.25 Apr 01, 2016: NICE provides positive guidance on electroCore s gammaCore treatment for the prevention and acute treatment of migraine and cluster headache | 84 | 1 |
| 6.26 Feb 29, 2016: Second Quarter Results ended December 31, 2015 - Ergoresearch reports its results for the quarter ended December 31, 2015 | 85 | 1 |
| 6.27 Feb 24, 2016: LivaNova Reports 2015 Annual and Fourth Quarter Financial Results | 85 | 3 |
| 6.28 Jan 19, 2016: University of Bonn study shows that non-invasive vagus nerve stimulation (nVNS) device reduces number of migraine attacks and their intensity | 88 | 1 |
| 6.29 Jan 06, 2016: ElectroCore Appoints Desitin to Launch gammaCore for the Treatment of Primary Headache across Germany | 89 | 1 |
| 6.30 Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter | 89 | 1 |
| 6.31 Dec 23, 2015: Mittel Plans to Sell 6% Interest in LivaNova | 90 | 1 |
| 6.32 Nov 19, 2015: Checkpoint Surgical Raises USD7.5 Million in Venture Financing | 90 | 1 |
| 6.33 Nov 12, 2015: LivaNova Provides Business Update | 90 | 3 |
| 7 Appendix | 93 | 4 |
| 7.1 Methodology | 93 | 2 |
| 7.2 About GlobalData | 95 | 1 |
| 7.3 Contact Us | 95 | 1 |
| 7.4 Disclaimer | 96 | 1 |